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Summary 29 
Limited uptake of minimally invasive surgery (MIS) of the aorta hinders assessment of its 30 
efficacy compared to median sternotomy (MS). The objective of this systematic review is to 31 
compare operative and perioperative outcomes for MIS vs MS. Online databases Medline, 32 
EMBASE, Cochrane Library, and Web of Science were searched from inception until July 33 
2018. Both randomized and observational studies of patients undergoing aortic root, 34 
ascending aorta, or aortic arch surgery by MIS vs MS were eligible for inclusion. Primary 35 
outcomes were 30-day mortality, reoperation for bleeding, perioperative renal impairment 36 
and neurological events. Intraoperative and postoperative timing measures were also 37 
evaluated. Thirteen observational studies were included comparing 1,101 MIS and 1,405 MS 38 
patients. The overall quality of evidence was very low for all outcomes. Mortality and the 39 
incidence of stroke was similar between the two cohorts. Meta-analysis demonstrated 40 
increased length of cardiopulmonary bypass (CPB) time for patients undergoing MS 41 
(standardized mean difference (SMD) 0.36, 95% confidence interval (CI) 0.15-0.58, 42 
p=0.001). Patients receiving MS spent more time in hospital (SMD 0.30, 95% CI 0.17-0.43, 43 
p<0.001), and intensive care (SMD 0.17, 95% CI 0.06-0.27, p<0.001). Reoperation for 44 
bleeding (risk ratio (RR) 1.51, 95% CI 1.06-2.17, p=0.024) and renal impairment (RR 1.97, 45 
95% CI 1.12-3.46, p=0.019) were also greater for MS patients. There was substantial 46 
heterogeneity in meta-analyses for CPB and aortic cross-clamp timing outcomes. MIS may 47 
be associated with improved early clinical outcomes compared to MS, but the quality of the 48 
evidence is very low. Randomized evidence is needed to confirm these findings.  49 
 50 
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Introduction 59 
Median sternotomy (MS) is the gold-standard surgical approach for dealing with thoracic 60 
aortic pathology, offering excellent exposure for access to the aorta and central cannulation 61 
[1]. The technical complexity and steep learning curves associated with minimally invasive 62 
surgery (MIS) of the aorta act as barriers, hindering the widespread adoption of these 63 
methods. Nevertheless, the proposed reduction in postoperative pain and hospital stay, 64 
alongside improved cosmesis in minimally invasive aortic valve surgery [2,3] make MIS 65 
techniques attractive.  66 
 67 
Well-established operations of the aortic root, such as the Bentall-De-Bono [4] and valve-68 
sparing root replacement (David) [5] procedures can now be performed via much smaller 69 
incisions. Additionally, minimal access techniques have proven to be diverse approaches, 70 
allowing the surgeon to carry out isolated or concomitant procedures of the aortic arch [6,7]. 71 
Numerous case series assessing MIS have found it to be safe in selected patients [8,9,10]. 72 
However, the paucity of comparative studies investigating MIS vs MS makes it difficult for 73 
surgeons to assess the true benefit of minimally invasive techniques in thoracic aorta 74 
surgery.  75 
 76 
The aim of this study is to comprehensively review the current body of evidence comparing 77 
MIS of the aorta with analogous procedures performed via MS. We performed a systematic 78 
review and meta-analyses to evaluate if MIS for pathologies of the aorta is a safe and 79 
feasible alternative to the current approach in terms of its perioperative outcomes.  80 
 81 
 82 
 83 
 84 
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Material and Methods   85 
The protocol for this review can be found on the PROSPERO website, registration 86 
number: CRD42018102726   87 
 88 
Selection Criteria   89 
Both randomized and observational studies of patients undergoing aortic root, ascending 90 
aorta, or aortic arch surgery comparing minimal access versus a MS were eligible for 91 
inclusion. Minimal access was defined as any incision type other than MS [11]. Studies were 92 
excluded if they did not have a comparison group, if they included patients receiving isolated 93 
aortic valve or abdominal aortic procedures only, or if more than 10% of study participants 94 
were emergency cases or had previous cardiac surgery. Studies performing concomitant 95 
procedures were included if the data for patients undergoing procedures of interest could be 96 
identified, or if 80% or more of the study patients underwent procedures of interest. No 97 
restriction was made on language or study size. Where multiple publications were available 98 
for the same cohort study, we used the data from the publication reporting the largest cohort 99 
and/or the most up to date results. To reduce the risk of publication bias, studies presenting 100 
only an abstract without a full text were included.   101 
 102 
Primary outcomes were 30-day mortality, reoperation for bleeding, perioperative renal 103 
impairment and neurological events. Intraoperative and postoperative timing measures were 104 
also evaluated. 105 
 106 
Literature Search Strategy   107 
Electronic searches were performed using Ovid Medline, Embase, the Cochrane Library, 108 
and the Web of Science from inception until July 2018. We combined the terms: (aorta or 109 
aortic or aortic root or aortic arch or ascending aorta) AND (surgical or surgeries or 110 
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replacement or operation or ministernotomy or hemisternotomy or hemi-sternotomy or mini-111 
sternotomy). All terms were searched as both text words and subject headings. The full 112 
search strategy is supplied in Supplementary Appendix 1. To look for further relevant 113 
literature we used the phrases “minimally invasive aortic surgery”, “minimally invasive aortic 114 
root/arch surgery”, and “minimally invasive ascending aorta surgery” to search websites and 115 
journals of relevance such as CTSnet and Annals of Cardiothoracic Surgery. The reference 116 
lists of included studies were reviewed to identify further potentially relevant studies. An 117 
expert cardiothoracic surgeon (H.V) was consulted regarding the existence of any 118 
unpublished material.  119 
  120 
Data Extraction and Critical Appraisal of Evidence   121 
Two reviewers (T.R & P.R) independently reviewed retrieved citations using Covidence 122 
systematic review software (Veritas Health Innovation, Melbourne, Australia). For all relevant 123 
records, full papers were retrieved and read in full by two reviewers independently (T.R & 124 
P.R).  Discrepancies were resolved by consensus, and where necessary inclusion of a third 125 
reviewer (J.S). Data extraction was completed by T.R and checked by P.R.   126 
  127 
Statistical Analysis  128 
We calculated the weighted arithmetic mean of patient baseline characteristics to look for 129 
differences between groups. For binary outcomes, we estimated the summary risk ratio (RR) 130 
and 95% confidence intervals from the reported number of events and participants from 131 
eligible studies. For continuous outcomes, we anticipated substantial variation between 132 
studies in terms of methods, technique, and operations performed making the raw mean 133 
difference less valid in a meta-analysis [12]. We therefore estimated the standardised mean 134 
difference (SMD) and its standard error (SE) from the reported means, standard deviations 135 
(SD) and numbers of participants [13], which accounts for some of these differences. If 136 
medians and inter-quartile ranges (IQR) were presented, the median was substituted for the 137 
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mean and the SD was estimated from the IQR [14] if we considered the distribution looked 138 
normal (i.e. the IQR was reasonably symmetrical about the median). Both fixed-effect and 139 
random-effects models were estimated and presented. Because of the technical differences 140 
in surgery of the aortic root and ascending aorta when compared to the aortic arch, we 141 
performed subgroup analysis and meta-regression for each outcome to assess if there was 142 
evidence of a difference between studies including and excluding arch procedures. The 143 
I2 statistic was used to estimate the percentage variation in the average treatment effect due 144 
to differences between studies [15]. We considered a value greater than 50% to represent 145 
substantial heterogeneity, and we considered potential reasons for such variation. The effect 146 
of small-study effect and publication bias was assessed using visual inspection of funnel 147 
plots [16]. P-values were two-tailed. Stata Version 15.1 (StataCorp LLC) was used for all 148 
statistical analysis.  149 
 150 
Assessment and Evaluation of the Quality of Evidence   151 
The risk of bias was assessed using the Risk of Bias in Non-Randomized Trials- of 152 
Interventions (ROBINS-I) tool [17]. ROBINS-I examines seven domains of 153 
bias: confounding, selection bias, bias in classification of interventions, bias due to 154 
deviations from intended interventions, bias due to missing data, bias in the measurement of 155 
outcomes, and bias in the selection of the reported result. Studies are judged to be at ‘low’, 156 
‘moderate’, ‘serious’, or ‘critical’ for risk of bias. Studies judged ‘critical’ were excluded 157 
from synthesis. The quality of evidence for each of the main outcomes was assessed using 158 
the GRADE scoring system [18], using GRADEpro software (available from 159 
www.gradepro.org).   160 
 161 
 162 
 163 
 164 
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Results 165 
Study selection and Characteristics of Included Studies  166 
Literature searches of online databases yielded 4430 citations and an additional 33 records 167 
were found from other sources. Of these, 143 relevant articles were read in full and 168 
assessed against the inclusion criteria, and 15 were included in the review 169 
[19,20,21,22,23,24,25,26,27,28,29,30,31,32,33]. After assessment of the risk of bias two 170 
studies were rated as having critical risk of bias and were not included in further analysis 171 
[27,29], thus leaving 13 studies for descriptive analysis. One further study was excluded 172 
from quantitative synthesis as no useable data existed for either binary or continuous 173 
outcomes [21]. Twelve studies were included in the quantitative synthesis, comprising 1,101 174 
patients in the MIS and 1,405 in the MS group. This information is shown in Figure 1 [34].  175 
 176 
Table 1 illustrates the characteristics of the inclu7ded studies. Three studies were only 177 
reported in abstracts from posters and conferences [20,21,30]. Less than 100 patients were 178 
investigated in three included articles [21,23,31]. Only one study involved more than 500 179 
participants [25]. Mean follow-up time was provided for only 4 studies [20,28,31,33].  180 
 181 
Patient Characteristics 182 
The weighted means of patient baseline characteristics were similar between MIS and MS 183 
groups (Supplementary Table 1): for example age (57.6 vs 58.0 years), sex (72.6% vs 184 
74.6% male), left ventricular ejection fraction (58.8% vs 58.1%), New York Heart Association 185 
functional class ≥3 (9.5% vs 11.2%), bicuspid aortic valve (58.1% vs 59.1%), hypertension 186 
(61.4% vs 63.9%), diabetes mellitus (7.2% vs 7.7%) and chronic obstructive pulmonary 187 
disease (7.1% vs 7.7%). The percentage of patients with aortic insufficiency (AI) grade ≥3 188 
was higher in the MIS group (57.3% vs 48.2%), although this was reported by only two 189 
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studies [28,33]. One study included 3 (1.5%) patients requiring emergency procedures [28], 190 
all remaining studies only included elective procedures.  191 
 192 
Interventions  193 
The indication, procedure, and concomitant procedures performed in the studies are 194 
summarised in Supplementary Table 2. The indication for operation varied between studies 195 
for the MIS and MS cohorts, though 10 articles reported aortic dilatation or aneurysm as an 196 
indication [19,20,23,24,25,26,28,31,32,33]. Aortic root replacement was performed in 12 197 
institutions [19,20,21,22,23,25,26,28,30,31,32] and ascending aorta replacement was 198 
performed in six centres [22,24,25,28,30,32]. Four studies reported operations of the aortic 199 
arch [24,28,32,33], with only one explicitly stating that they performed complete arch 200 
replacement [28].  There were differences in the proportion of patients in the MIS and MS 201 
cohorts receiving each primary aortic intervention in seven studies [20,22,23,25,28,30,32]. 202 
The Bentall procedure was performed by six institutions [19,20,22,26,30,32], and eight 203 
institutions operated on the aortic valve concomitantly [22,23,24,25,28,30,32,33]. Other 204 
additional procedures were performed by three institutions [23,28,33] and included mitral 205 
valve surgery and coronary artery bypass grafting. The proportion of patients receiving each 206 
of these concomitant procedures was in general greater for the MS cohort in two studies 207 
[23,33], whilst in one study MIS patients were more likely to undergo additional surgery [28].   208 
 209 
The ‘J’ ministernotomy to the third or fourth intercostal space was used in all but one study, 210 
instead opting for a right or right lateral thoracotomy [24]. One study also performed MIS 211 
through an ‘inverted-T’ ministernotomy [19]. The cannulation technique and strategies for 212 
myocardial protection varied widely between studies. They are presented in Supplementary 213 
Table 3. Only one study fully described their cannulation technique for both MIS and MS 214 
cohorts [22].  215 
 216 
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Five studies commented that they gained experience with aortic surgery via MS prior to 217 
progressing to MIS [18,22,24,26,28]. Four studies stated that a single surgeon performed 218 
the procedures at their institution for both MS and MIS groups [21,22,24,26]. In one study, 219 
five surgeons performed aortic surgery via MS, whilst only two of this five operated on the 220 
MIS group [28]. The remaining studies did not report issues related to the surgical learning 221 
curve. 222 
 223 
Risk of Bias in Included Studies 224 
All included studies were non-randomized and their risk of bias is shown in Supplementary 225 
Table 4. We judged two studies to be at critical risk of bias due to the presence of strong 226 
unadjusted confounding [27,29]. Ten included studies were at ‘serious’ risk of bias 227 
[20,21,22,23,24,25,26,28,29,32], mainly due to confounding, one was at ‘moderate’ risk of 228 
bias [33], and one study provided insufficient information to make a risk of bias judgement 229 
[29]. Three studies undertook propensity-score matched analyses [24,25,28] and three 230 
studies used matched-pair analysis to control for specific patient baseline characteristics 231 
[22,32,33].  232 
 233 
Synthesis of Evidence by Outcome 234 
The timing outcomes and the main clinical findings for the included studies are presented in 235 
Supplementary Table 5 and Supplementary Table 6 respectively. Results of meta-analyses 236 
for perioperative mortality, reoperation for bleeding, renal impairment, stroke, aortic cross-237 
clamp (AoX) time, CPB time, and length of intensive care unit (ITU) and hospital stay are 238 
presented in Table 2. The quality of the overall body of evidence was very low for all 239 
outcomes as defined by GRADE criteria [18].  240 
 241 
The reported use of packed red blood cells (pRBC) suggested a skewed distribution, 242 
invalidating the method of converting medians to means, making meta-analysis unfeasible.  243 
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Perioperative Mortality 244 
There were more observed postoperative deaths in the MS cohort, however the number of 245 
events occurring across all 12 studies was low and thus there was little evidence that rates 246 
of post-operative mortality differed between MIS and MS (RR 1.74, 95% CI 0.70-4.37, 247 
p=0.24; Figure 2). There was no evidence that mortality was influenced by the inclusion of 248 
arch procedures (p for difference= 0.772). There was no evidence of heterogeneity (I2= 249 
0.0%, p= 0.99). The funnel plot demonstrated no visual asymmetry (Supplementary Figure 250 
1).  251 
 252 
Reoperation for Bleeding and Use of Blood Products.  253 
Reoperation for bleeding occurred more commonly in MS patients (RR 1.51, 95% CI 1.06-254 
2.17, p=0.024; I2= 0.0, p= 0.83; Figure 3). There was some evidence that reoperation was 255 
influenced by the inclusion of arch surgery (RR 2.00, 95% CI 1.01-3.93 for studies including 256 
arch surgery, RR 1.36, 95% CI 0.89-2.07 for studies excluding arch surgery, p for difference 257 
= 0.0368). The funnel plot for the reoperation outcome demonstrated asymmetry which is 258 
suggestive of small-study effect or publication bias [35,36] (Figure 4).  259 
 260 
A greater number of pRBC units were transfused in the MS compared with MIS cohort, in 261 
eight of the nine studies reporting this outcome [19,22,24,26,28,31,32,33]. Mean number of 262 
units transfused across studies ranged from 1.3 to 6.7 units to 0.89 to 4.9 units for MS and 263 
MIS patients, respectively.   264 
 265 
Renal Impairment and Neurological Events  266 
There was some evidence to suggest that postoperative renal impairment was greater in the 267 
MS cohort (RR 1.97, 95% CI 1.12-3.46, p=0.019; I2= 0.0, p=0.99; Supplementary Figure 2a). 268 
There was no evidence that renal impairment was influenced by the inclusion of arch 269 
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procedures (p for difference = 0.836). The funnel plot for the renal impairment outcome 270 
appeared symmetrical (Supplementary Figure 2b).  271 
 272 
Four studies reported perioperative stroke [25,28,30,32] but there were few events and so 273 
there was no evidence of a difference in the incidence of stroke for MIS vs MS patients (RR 274 
1.06, 95% CI 0.50-2.26, p=0.887; I2 = 0.0, p=1.0; Supplementary Figure 3a). There was no 275 
evidence that the incidence of stroke was influenced by the inclusion of arch procedures (p 276 
for difference =0.951). The funnel plot appeared symmetrical for the stroke outcome 277 
(Supplementary Figure 3b). One study found postoperative delirium to be increased for MS 278 
patients [33].  279 
 280 
Aortic cross-clamp & cardiopulmonary bypass Time 281 
Patients undergoing MS for their aortic pathology had longer AoX times (SMD 0.16, 95% CI 282 
-0.03-0.36, p=0.091; I2 = 70.7, p<0.001; Supplementary Figure 4a). However, there was 283 
substantial heterogeneity between the studies and there was little evidence of difference 284 
between groups in the random effects model. The funnel plot appeared symmetrical 285 
(Supplementary Figure 4b).  286 
 287 
There was some evidence to suggest that patients in the MS cohort were subject to 288 
increased CPB time, but the heterogeneity between studies was substantial (SMD 0.36, 289 
95% CI 0.15-0.58, p=0.001; I2=76.5, p=0.001; Supplementary Figure 5a). No asymmetry 290 
was observed in the funnel plot for this outcome (Supplementary Figure 5b).  291 
 292 
There was no evidence the inclusion of arch procedures influenced the AoX (p for difference 293 
= 0.614) or CPB time (p for difference = 0.849).  294 
 295 
 296 
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Length of ICU and Hospital Stay 297 
Patients undergoing MS spent more time in ICU (SMD 0.17, 95% CI 0.06-0.27, p<0.001; I2= 298 
7.2%, p=0.37; Supplementary Figure 6a). There was no strong evidence of a difference in 299 
ICU length of stay with the inclusion of arch procedures (p for difference = 0.085). There was 300 
no evidence of asymmetry in the funnel plot (Supplementary Figure 6b).  301 
 302 
The length of hospital stay was longer for the MS group (SMD 0.30, 95% CI 0.17-0.43, 303 
p<0.001; I2=16.5, p=0.30; Supplementary Figure 7a). There was no evidence the inclusion of 304 
arch procedures influenced the hospital length of stay (p for difference = 0.753). The funnel 305 
plot was symmetrical (Supplementary Figure 7b).   306 
 307 
Discussion  308 
 309 
To the best of our knowledge, the present study represents the first systematic review and 310 
meta-analysis comparing outcomes of all aortic surgery by MIS versus MS. The overall 311 
quality of the body of evidence was very low [18] for all outcomes, thus all findings should be 312 
interpreted with caution. We found no significant difference in mortality between MIS and 313 
MS, although MIS was associated with reduced rates of reoperation for bleeding, renal 314 
impairment, ICU stay, hospital length of stay and CPB time. There was no significant 315 
difference in AoX time between patient groups. The incidence of stroke was low and meta-316 
analysis did not demonstrate a difference between MIS and MS patients. Although meta-317 
analysis was not possible, fewer pRBC units were transfused for MIS patients in all but one 318 
study that reported the outcome [23]. We found no strong evidence that the inclusion of arch 319 
procedures influenced all outcomes except reoperation for bleeding. Our review highlights 320 
that MIS of the aorta is a highly versatile approach that facilitates surgery of the aortic root, 321 
ascending aorta, and aortic arch for a diversity of indications. Despite the limitations of the 322 
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available evidence, our findings suggest that MIS of the aorta may be a feasible alternative 323 
to MS. Robust randomised studies are needed to support this conclusion.  324 
 325 
The strengths of this systematic review include the comprehensive search to identify all 326 
available evidence and the rigorous methods of study selection, with two independent 327 
reviewers. Our systematic review was conducted according to the highest standards of 328 
review conduct [37]. We designed a comprehensive and sensitive search strategy, with input 329 
from two professional information scientists, to identify as many relevant studies as possible 330 
and reduce the risk of publication bias. We searched multiple electronic databases, 331 
additional relevant sources, and references of relevant studies were inspected for further 332 
studies. We did not impose date or language restrictions. Study selection was performed 333 
independently by two reviewers and data extraction was carried out by one reviewer and 334 
checked by another. We used the ROBINS-I [17] tool to assess the risk of bias in included 335 
observational studies, the most comprehensive tool for assessing risk of bias in non-336 
randomized studies of interventions. We assessed the overall quality of the body of evidence 337 
according to GRADE recommendations and followed Cochrane recommendations for 338 
conducting meta-analyses [13].  339 
 340 
The reduction in the CPB time for MIS patients in our review contradicts current trends in 341 
minimally invasive cardiac surgery [2,38]. It is well-established that prolonged time on CPB 342 
increases the risk of neurological [39] and perioperative renal impairment [40]. There was 343 
substantial heterogeneity in this meta-analysis, with the Levack study [25] contributing the 344 
most weight to the estimate. We could not identify specific study characteristics that could 345 
explain the observed heterogeneity in CPB times across studies. One possible explanation 346 
for this finding is that patients receiving MIS may have undergone procedures that 347 
demanded less time on CPB when compared to the MS group. Moreover, many of the 348 
institutions in the included studies gained sufficient experience of aortic surgery via MS 349 
before graduating to MIS. This would have the effect on minimising the surgeon learning 350 
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curve for performing MIS of the aorta. Therefore, surgeons with less experience of MIS may 351 
require longer CPB time than in the included studies of this review. However, it is noteworthy 352 
that most institutions opted for a ministernotomy. This incision enables the surgeon to 353 
visualise a similar operating field when compared to MS. Therefore, the difference in CPB 354 
time should not vary considerably for MIS of the aorta versus MS, and the clinical 355 
significance of any difference is probably minimal. 356 
 357 
Our study also reports a reduction in the number of patients undergoing reoperation for 358 
bleeding in the MIS group. Reoperation keeps patients in hospital, and brings with it the risks 359 
of reopening the chest [41]. Minimally invasive cardiac surgery has been theorised to reduce 360 
bleeding, possibly due to reduced sternal trauma and instability. However, the visually 361 
asymmetrical funnel plot indicates the presence of small-study effect or publication bias; the 362 
latter of which would result in a favourable interpretation of the benefits of MIS on the rate of 363 
reoperation. Selective reporting and publication bias precludes accurate interpretation of the 364 
potential benefits of MIS and so it is key that surgeons report all data regardless of the 365 
outcome in future studies. Meta-regression analysis suggested that reoperation rates might 366 
be lower in studies which included aortic arch surgery. Though interesting, the proportion of 367 
arch procedures was relatively low in the included studies, so this finding is likely to 368 
be related to other differences between studies. 369 
 370 
Although we were unable to quantitatively analyse the transfused pRBC outcome, fewer 371 
pRBC units were transfused in the MIS cohort in eight of the nine studies reporting the 372 
outcome. This may reflect a tendency of surgeons to pay closer attention to haemostasis in 373 
MIS compared to MS, and the possibility that the threshold for giving blood products may 374 
have differed for MIS and MS patients. Nevertheless, these results provide some 375 
reassurance that MIS of the aorta does not lead to a greater quantity of blood transfusion, 376 
which has the potential for minimising morbidity [42] and cost to health services.  377 
 378 
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There was some evidence that MIS was associated with a reduction in both ICU and 379 
hospital length of stay. This finding is consistent with the current literature for minimal access 380 
cardiac surgery [2,38,43]. Prolonged periods in ICU are associated with perioperative 381 
morbidity and mortality [44], and so minimising this would be an important advantage of MIS 382 
of the aorta. Whether the result in our review occurred because of the effect of MIS rather 383 
than differences in postoperative care for MIS and MS patients requires consideration. All 384 
included studies reporting the length of hospital stay found the time in hospital to be shorter 385 
for MIS patients. This could be a consequence of attenuated postoperative pain, although 386 
the lack of data on this outcome does not allow us to make firm conclusions. Future studies 387 
should endeavour to report this very important outcome.  388 
 389 
It is challenging to recommend a means of approaching MIS of the aorta given the marked 390 
variation in the way surgeons undertake these procedures (e.g. cannulation and myocardial 391 
protection). This is often dictated by surgeon preference given their experiences with similar 392 
procedures performed through MS. Surgeons contemplating utilising MIS may wish to first 393 
gain sufficient experience with aortic surgery via MS before undertaking MIS. Shreshta and 394 
colleagues performed more than 500 David procedures via a MS at their institution and more 395 
than 200 minimal access aortic valve replacements prior to undertaking MIS of the aorta 396 
[45]. This enabled them to adequately develop a routine approach to these procedures 397 
which minimises the challenge of converting to MIS of the aorta. Moreover, the authors 398 
initially selected low-risk patients with isolated aortic disease to undergo MIS. We therefore 399 
emphasise the need for prolonged experience with MIS of the aorta and careful patient 400 
selection in the early stages of a MIS programme.  401 
 402 
A limitation of the evidence included in our review is that it is based on single centre, non-403 
randomized studies which are vulnerable to confounding and other biases. There was 404 
heterogeneity in the CPB and AoX time that was not explained by the inclusion of arch 405 
procedures. Therefore, it is likely that this variation occurred due to other confounding 406 
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variables such as differences in indication, type of surgery, and the performance of 407 
concomitant procedures between studies. To mitigate the impact of concomitant procedures 408 
such as aortic valve surgery on the outcomes of MIS, further studies should aim to compare 409 
isolated aortic surgery for MIS versus MS. The overall quality of the body of evidence was 410 
very low for all outcomes, as defined by the GRADE criteria [18]. As only a few of the studies 411 
had long-term follow-up, we were unable to evaluate the differences in long term aortic 412 
complications between the two approaches. Moreover, we were not able to assess important 413 
measures of patient satisfaction such as quality of life and time to return to work. These 414 
outcomes should be addressed in future studies to establish whether MIS of the aorta is of 415 
benefit to patients.  416 
 417 
Conclusion  418 
Very low quality non-randomized evidence suggests that MIS of the aorta may be 419 
associated with improved early clinical outcomes when compared to MS. Randomized 420 
controlled trials are essential to confirm these findings.   421 
 422 
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Fig 1. 
 
PRISMA flow chart of the search and study selection process.  
Fig 2.  
Early postoperative mortality in patients undergoing minimally invasive surgery (MIS) of the aorta vs median sternotomy (MS). (M-H = Mantel-
Haenszel test; D+L= DerSimonian-Laird test.) Solid squares for each study represent the risk ratio (RR) with the size proportional to the 
weights in meta-analysis. The horizontal lines denote the 95% confidence intervals (95% CI). A RR of 1 (vertical black line) indicates no 
difference between MIS and MS. The uppermost diamond represents the fixed effect model weighted RR. The bottommost diamond illustrates 
the random-effects weighted RR. The horizontal tips of the diamond are the confidence interval for the overall effect estimate.  
Fig 3. 
The requirement to reoperate for bleeding in patients undergoing minimally invasive aortic surgery (MIS) vs median sternotomy (MS). (M-H = 
Mantel-Haenszel test; D+L= DerSimonian-Laird test.) Solid squares for each study represent the risk ratio (RR) with the size proportional to the 
weights in meta-analysis. The horizontal lines denote the 95% confidence intervals (95% CI). A RR of 1 (vertical black line) indicates no 
difference between MIS and MS. The uppermost diamond represents the fixed effect model weighted RR. The bottommost diamond illustrates 
the random-effects weighted RR. The horizontal tips of the diamond are the confidence interval for the overall effect estimate.  
Fig 4 
Funnel plot for the reoperation for bleeding outcome. Individual blue circles indicate studies included in the present study. The position of these 
circles along the horizontal axis represents the effect-estimate/risk ratio (RR). This is plotted against the standard error (SE) of the log-RR 
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which is an estimate of study precision. Asymmetry is suggestive of small-study or publication bias causing overestimation of the effect size in a 
meta-analysis.  
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Table 1 
Characteristics of studies included in this systematic review & meta-analysis comparing minimally invasive aortic surgery with median 
sternotomy. 
 21 
First Author & 
Year [ref no.] 
 
Study 
Period 
 
Country, Treatment 
Centre 
 
Study 
Design 
 
n  
(MIS) 
 
n  
(MS) 
 
MIS Incision 
 
Mean Follow-up 
Time 
(months) 
Comment 
MIS MS                       
Abjigitova 2018 
[19] 
1998-2016 The Netherlands, 
Rotterdam 
OC, 
RSP 
26 91 ‘J’ ministernotomy 
or ‘inverted T’ 
ministernotomy 
- -  
Aharon 2017 
[20] 
1998-2016 USA, Wynnewood, 
PA 
OC, RSPa 26 199 Ministernotomy 22.3 158.3 Type of 
ministernotomy not 
defined 
Burdett 2014 
[21] 
2012-2013 UK, Middlesborough OC, RSPa 7 9 Ministernotomy - - Type of 
ministernotomy not 
defined 
Hastaoglu 2018 
[22] 
 
2010-2015 
 
Turkey, Istanbul MC 54 75 ‘J’ ministernotomy” 
 
- - 
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Hillebrand 2018 
[23] 
2012-2016 Germany, Münster OC, RSP 33 25 ‘J’ ministernotomy - -  
Lamelas 2018 
[24] 
2009-2014 USA, Houston, TX PSM 74 103 MI right 
thoracotomy OR 
right lateral 
thoracotomy 
- -  
Levack 2017 
[25] 
1995-2014 USA, Cleveland, OH PSM 568 1259  ‘J’ ministernotomy - 
 
-  
Mikus 2017 [26] 2010-2015 Italy, Ravenna OC, RSP 
 
53 185 ‘J’ ministernotomy - -  
Monsefi 2018 
[27] 
1991-2015 Germany, Frankfurt OC, RSP 90 206 ‘J’ ministernotomy 36±24 96±48 Critical Risk of Bias 
Monsefi 2018 
[28] 
  
1991-2016 
 
Germany, Frankfurt PSM 120 207 ‘J’ ministernotomy 36±24 96±48  
Shreshta 2015 
[29] 
2011-2014 Germany, Hannover OC, RSP 26 14 ‘J’ ministernotomy 40±27 41±26 Critical Risk of Bias 
 23 
 
a= abstract; MC= matched cohort; MIS= minimally invasive surgery; MS= median sternotomy; OC= observational cohort, RSP= retrospective; 
PSM= propensity score matched 
±= range 
†= The authors stated that patients were followed-up for at least 3 months for both cohorts. 
 
 
 
 
 
 
Shreshta 2018 
[30] 
2011-2016 Germany, Hannover OC, RSPa 210 192 ‘J’ ministernotomy - -  
Sun 2000† [31] 1999-1999 China, Beijing OC, RSP 8 21 ‘J’ ministernotomy 3 3  
Tabata 2007 
[32] 
1996-2005 USA, Boston, MA MC 128 93 ‘J’ ministernotomy - -  
Wachter 2017 
[33] 
2007-2012 Germany, Stuttgart MC 117 75 ‘J’ ministernotomy 31±18 31±18  
 24 
Table 2. 
Summary of perioperative characteristics and outcomes with quality of evidence assessment for analysed outcomes by the Grades 
of Recommendation, Assessment, Development and Evaluation Working Group Approach (GRADE). 
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Minimally Invasive Aortic Surgery vs. Median Sternotomy 
 
Population or patient: Patients Undergoing Minimally Invasive Aortic Surgery 
Setting: Inpatient Hospital Setting 
Interventions: All Minimally Invasive Procedures of The Aortic Root/Arch and Ascending Aorta 
Comparator: Median Sternotomy 
 
 
Outcome Quality of 
Evidence for 
Outcome (GRADE) 
With 
Justification(s) 
No. of 
studies 
No. of 
patients 
in MIS 
Events 
in MIS 
group 
(%) 
No. of 
patients 
in MS 
Events in 
MS group 
(%) 
RR (95% CI) 
 
 
P value for 
overall effect 
Heterogeneity 
 
 
Fixed Random Fixed Random I2 (%) P value 
 Major outcomes 
Mortality  
1, 3, 4 
9 1039 0.67 1328 1.73 1.96 
(0.81-
4.76) 
1.74 
(0.70-
4.37) 
0.14 0.24 0.0 0.99 
Reoperation 
for bleeding 
 
1, 3, 4, 5 
12 1168 
 
4.07 1470 7.10 1.61 
(1.13-
2.29) 
1.51 
(1.06-
2.17) 
0.008 0.024 0.0 0.83 
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Renal 
Impairment 
  
1, 3, 4 
7 899 1.56 1194 3.52 1.99 
(1.13-
3.51) 
1.97 
(1.12-
3.46) 
0.017 0.019 0.0 0.99 
Stroke  
 
1, 3, 4 
4 875 1.49 857 1.52 1.06 
(0.50-
2.25) 
1.06 
(0.50-
2.26) 
0.89 0.89 0.0 1.0 
 Operative outcomes                                                                 
 
SMD (95% CI)  
Fixed Random 
AoX time  
1, 2, 3 
11 955 - 1275 - 0.26 
(0.17-
0.34) 
0.16 (-
0.03-
0.36) 
<0.001 0.091 70.7 <0.001 
CPB time  
1, 2, 3 
 
11 955 - 1275 - 0.36 
(0.15-
0.44) 
0.36 
(0.15-
0.58) 
<0.001 0.001 76.5 <0.001 
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AoX= aortic cross-clamp CI= confidence interval; CPB= cardiopulmonary bypass; ITU= intensive care unit; MIS= minimally invasive 
surgery; MS= median sternotomy; RR= risk ratio; SMD= standardised mean difference 
 
Quality of Evidence  
    = Very Low,   = Low;   = Moderate;   = High   
Limitation in Design: 
1 Potential risk of bias  
2 Heterogeneity- possibly not explained  
3 Small number of events and/or small sample size and/or small number of studies reporting outcome  
4 Wide confidence intervals for effect estimate suggestive of imprecision  
5 Suspicion of publication bias confirmed by funnel plot
Length of ICU 
stay  
 
1, 3 
8 805 - 952 - 0.15 
(0.06-
0.25) 
0.17 
(0.06-
0.27) 
<0.001 <0.001 7.2 0.37 
Length of 
Hospital stay 
 
1, 3 
7 684 - 831 - 0.31 
(0.21-
0.41) 
0.30 
(0.17-
0.43) 
<0.001 <0.001 16.5 0.30 
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Supplementary Appendix 1 
Search strategies for the electronic databases used in this review 
Search Strategy for Embase & Medline 
 
1. Aorta/ 
2. ((aortic or aorta) adj4 (operation* or replace* or surgery)).tw. 
3. (aortic adj (root or arch or ascending)).tw. 
4. 1 or 2 or 3 
5. Surgical Procedures, Minimally Invasive/ 
6. ((surgical or surgery or surgeries or replacement* or operation*) adj3 minim*).tw. 
7. ((surgery or surgeries or surgical) adj3 (keyhole or percutaneous or robot-
assisted)).tw. 
8. (ministernotom* or hemisternotom* or hemi-sternotomy or mini-sternotomy).tw. 
9. 5 or 6 or 7 or 8  
10. 4 and 9  
 
Search Strategy for Web of Science 
 
1. TS=Aorta 
2. TS= ((aortic or aorta) NEAR/4 (operation* or replace* or surgery)) 
3. TS=(aortic NEAR (root or arch)) 
4. #3 OR #2 OR #1 
5. TS= Surgical Procedures, Minimally Invasive 
6. TS=((surgical or surgery or surgeries or replacement* or operation*) NEAR/3 minim*) 
7. TS= ((surgery or surgeries or surgical) NEAR/3 (keyhole or percutaneous or robot-
assisted) 
8. TS= (ministernotom* or hemisternotom* or hemi-sternotomy or mini-sternotomy) 
9. #8 OR #7 OR #6 OR #5 
10. #9 AND #4 
 Search strategy for the Cochrane Library  
1. Aorta  
2. ((aortic or aorta) near (operation* or replace* or surgery))  
3. (aortic near (root or arch or ascending))  
4. 1 or 2 or 3  
5. Surgical Procedures, Minimally Invasive  
6. ((surgical or surgery or surgeries or replacement* or operation*) near minim*)  
7. ((surgery or surgeries or surgical) near (keyhole or percutaneous or robot-
assisted))  
8. (ministernotom* or hemisternotom* or hemi-sternotomy or mini-sternotomy)  
9. 5 or 6 or 7 or 8  
10. 4 and 9  
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 1.  
Baseline characteristics for the patients included in studies comparing minimally invasive surgery of the aorta with median sternotomy. 
 
Author et 
al. [ref no.] 
Mean age in 
years SD 
 
  Sex n (% 
male) 
LVEF % SD NYHA≥3 n (%) AI≥3 
n (%) 
BAV n (%) HTN n (%) DM n (%) COPD n (%) 
 MIS 
 
MS MIS 
 
MS MIS MS MIS MS MIS MS MIS MS MIS MS MIS MS MIS MS 
Abjigitova 
[19] 
57 SD 
12 
57 SD 
13 
23 
(88.5) 
74 
(81.3) 
60 SD 
7.4 
60 SD 
7.4 
- - 10 
(38.8) 
28 
(30.8) 
18 
(69.2) 
74 
(81.3) 
1 
(3.8) 
7 
(7.7) 
2 
(7.7) 
12 
(13.2) 
Aharon 
[20] 
 
56 SD 
12.9 
57.6 
SD  
13.5 
 23 
(88.5) 
161 
(80.7) 
- - - - - - - 
Burdett 
[21] 
 
 
- - - - - - - - - - 
Hastaoglu 
[22] 
57.9 
SD 
12.5 
58.4 
SD 
9.6 
33 
(73.3) 
33 
(73.3) 
60.9 
SD 6.3 
61.9 
SD 6.0 
- - - 29 
(64.4) 
27 
(60.0) 
8 
(17.8) 
6 
(13.3) 
- 
Hillebrand 
[23] 
 
 
55.6 
SD 
13.2 
59.1 
SD 
12.5 
24 
(72.7) 
18 
(72.0) 
- - - 14 
(42.4) 
2 
(8.0) 
20 
(60.6) 
19 
(76.0) 
5 
(15.2) 
3 
(12.0) 
3 
(9.1) 
3 
(12.0) 
Lamelas 
[24] 
63.3 
SD 
13.5 
63.2 
SD 
13.7 
37 
(58.7) 
39 
(61.9) 
59.0 
SD 
8.4 
58.0 
SD 
9.4 
- - 40 
(63.5) 
16 
(25.4) 
50 
(79.4) 
50 
(79.4) 
10 
(15.9) 
13 
(20.6) 
5 
(7.9) 
4 
(6.3) 
Levack 
[25] 
 
 
56 SD 
14 
55 SD 
14 
351 
(73.0) 
364 
(75.0) 
- 34 
(7.7) 
32 
(7.2) 
- - 293 
(61.0) 
285 
(59.0) 
23 
(4.8) 
30 
(6.2) 
36 
(7.5) 
36 
(7.5) 
Mikus [26] 
 
 
61 SD 
13.3 
64 SD 
11.7 
44 
(83.0) 
93 
(83.0) 
61 SD 
8.8 
58.3 
SD 
9.7 
8 
(15.0) 
24 
(22.0) 
- 27 
(51.0) 
41 
(36.0) 
32 
(60.0) 
78 
(70.0) 
4 
(7.0) 
9 
(8.0) 
4 
(7.0) 
10 
(9.0) 
Monsefi 
[28] 
 
 
57 SD 
14 
57 SD 
13 
29 
(77.0) 
29 
(77.0) 
60 SD 
10 
57 SD 
10 
- 58 
(56.0) 
56 
(54.0) 
23 
(22.3) 
17 
(13.1) 
51 
(50.0) 
56 
(54.0) 
- - 
Shreshta 
[30] 
 
 
60 SD 
14 
63 SD 
13 
137 
(65.2) 
114 
(59.4) 
- - - - - - - 
 AI= aortic insufficiency; BAV= bicuspid aortic valve; COPD= chronic obstructive pulmonary Disease; DM= diabetes mellitus; HTN= hypertension; 
LVEF= left ventricular ejection fraction; MIS= minimally invasive surgery; MS= median sternotomy; NYHA= New York Heart Association functional 
class; SD= standard deviation 
Data are presented as number (n) and percentage (%). Mean age in years is presented with its SD. Left ventricular ejection fraction is expressed 
as a percentage (%) with its SD. 
 
 
Sun [31] 
 
41.6 
SD 
8.2 
40.8 
SD 
10.1 
6 
(75.0) 
19 
(90.5) 
60.1 
SD 
11.5 
56.8 
SD 
12.3 
- - - - - - 
Tabata [32] 
 
 
55 SD 
13 
54 SD 
14 
60 
(76.0) 
60 
(76.0) 
56 SD 
11 
54 SD 
13 
13 
(16.5) 
16 
(20.2) 
- 35(44.3
) 
30 
(38.0) 
- 3(3.8) 2(2.5) 4(5.1) 5(6.3) 
Wachter 
[33] 
65.5 
SD 
9.9 
65.9 
SD 9.5 
27 
(75.0) 
42 
(77.8) 
54.6 
SD 
12.8 
60.2 
SD 
12.6 
- 22 
(61.1) 
20 
(37.0) 
- - 5 
(13.9) 
3˙ 
(5.6) 
2 
(5.6) 
6 
(11.1) 
Minimum 
 
41.6 40.8 58.7 59.4 54.6 54 7.73 7.20 56.0 37.0 22.3 8.0 50.0 54.0 3.8 2.5 5.1 6.3 
Maximum 
 
65.9 65.9 88.5 90.5 61 61.91 16.5 22.0 61.1 54.0 63.5 36.0 79.4 81.3 17.8 20.6 9.1 13.2 
Weighted 
Mean 
57.6 58.0 72.6 74.6 58.8 58.1 9.48 11.2 57.3 48.2 58.1 59.1 61.4 63.9 7.2 7.7 7.14 7.74 
 Supplementary Table 2.   
The indication for surgery, type of surgery performed, and the utilisation of concomitant procedures for studies comparing minimally invasive 
surgery of the aorta with median sternotomy. 
 
 
Author et 
al. [ref no.] 
Indication for surgery Primary procedure(s) Concomitant procedures 
 
 MIS MS MIS MS MIS MS 
Abjigitova 
[19] 
Medial degeneration 
(88.5%); endocarditis 
(7.7%) 
Chronic dissection 
(9.9%); medial 
degeneration (72.5%); 
endocarditis (2.2%); 
aortitis (1.1%) 
 
Bentall (100%) Bentall (100%) All patients received AV replacement 
Aharon 
[20] 
Medial degeneration 
(57.8%) 
Medial degeneration 
(76.9%)  
Bentall (84.6%); David (15.4%)  
 
Bentall (83.9%); David (16.1%) NI 
Burdett 
[21] 
NI NI Isolated aortic root replacement 
(100%) 
Isolated aortic root replacement 
(100%) 
Not included  
Hastaoglu 
[22] 
  
"Pathology of the proximal aorta" Ascending aorta replacement 
(40.0%); AV replacement + aortic 
root replacement (40%); Bentall 
(20%) 
Ascending aorta replacement 
(33.3%); AV replacement + aortic 
root replacement (42.2%); Bentall 
(24.4%) 
See ‘primary 
procedures’  
See ‘primary 
procedures’  
Hillebrand 
[23] 
Aortic root dilation Aortic root dilation Aortic root replacement using a 
valved conduit. Mechanical 
conduit (57.6%); biological conduit 
(42.4%) 
Aortic root replacement using a 
valved conduit. Mechanical 
conduit (48%); biological conduit 
(52%) 
 
Mitral valve 
repair/replacement 
(9.1%); tricuspid 
valve repair 
Mitral valve 
repair/replacement 
(12%); tricuspid 
valve repair (8%) 
(6.1%); closure of 
PFO (3%) 
Lamelas 
[24] 
Patients requiring circulatory arrest for pathology 
of the ascending aorta (aneurysm) with or without 
AV involvement 
 
Ascending aorta replacement with AV replacement; ascending aorta 
replacement with AV replacement & hemiarch replacement. No 
breakdown provided. However, those with aneurysms extending to the 
arch, who required valve-sparing operation, and those requiring 
coronary revascularisation received median sternotomy. 
 
AV replacement. No breakdown 
provided 
Levack 
[25] 
AV regurgitation (69%); 
AV stenosis (43%); 
ascending aortic 
aneurysm or aortic root 
dilatation (30%) 
AV regurgitation (71%); 
AV stenosis (43%); 
ascending aortic 
aneurysm or aortic root 
dilatation (29%) 
Aortic root reimplantation 
(0.83%); remodelling (0.41%); 
resuspension (6%); valved 
conduit (15%); isolated 
ascending aorta repair (1%); 
ascending aorta repair with AV 
repair (1.4%); ascending aorta 
repair with AV replacement 
(3.7%); isolated ascending 
aorta replacement (6%); 
ascending aorta replacement 
with AV repair (23%); 
ascending aorta replacement 
with AV replacement (43%) 
Aortic root reimplantation (12%); 
remodelling (1%); resuspension 
(5.2%); valved conduit (19%); 
isolated ascending aorta repair 
(0.21%); ascending aorta repair with 
AV repair (1.4%); ascending aorta 
repair with AV replacement (6.2%); 
isolated ascending aorta 
replacement (7.5%); ascending aorta 
replacement with AV repair (8.3%); 
ascending aorta replacement with 
AV replacement (40%) 
 
See ‘primary procedures’  
 
Mikus [26] Chronic aneurysm due 
to calcified 
degenerative disease 
NI Bentall-De-Bono (100%) Bentall-De-Bono (100%) All patients received AV replacement 
(45.3%); annuloaortic 
ectasia (50.9%); 
infective chronic 
endocarditis (3.8%) 
 
Monsefi 
[28] 
Aortic root aneurysm 
with or without AV 
incompetence (100%) 
Aortic root aneurysm 
with or without AV 
incompetence (100%) 
Neosinus (96.1%); 
pseudosinus (0.97%); standard 
David (2.91%); isolated 
ascending aorta replacement 
(72%); ascending aorta + 
hemiarch replacement (10%); 
complete arch replacement 
(12%); elephant trunk (6%) 
Neosinus (40.8%); pseudosinus 
(16.5%); standard David (42.7%); 
isolated ascending aorta 
replacement (66%); ascending aorta 
+ hemi-arch replacement (27%); 
complete arch replacement (3%); 
elephant trunk (3%) 
 
CABG (5%); ASD 
closure (2%); 
mitral valve repair 
(10%); tricuspid 
valve repair (3%); 
leaflet plication of 
the AV (50%); 
supra-annular 
stitch (54%) 
CABG (7%); ASD 
closure (1%); 
mitral valve repair 
(2%); tricuspid 
valve repair (2%); 
leaflet plication of 
the AV (42%); 
supra-annular 
stitch (17%) 
Shreshta 
[30] 
NI NI Isolated ascending aortic 
replacement (19.5%); AV 
replacement with supra-
commissural ascending aorta 
replacement (30.5%); Bentall 
(26.2%); David (21.9%) 
Isolated ascending aortic 
replacement (25%); AV replacement 
with supra-commissural ascending 
aorta replacement (33.9%); Bentall 
(27.1%); David procedure (14.1%) 
 
See ‘primary procedures’  
Sun [31] Proximal aortic 
aneurysm with aortic 
regurgitation (100%) 
Proximal aortic 
aneurysm with aortic 
regurgitation (100%) 
 
David (100%) David (100%) Not included 
Tabata 
[32] 
Aortic aneurysm 
(58.2%); chronic aortic 
dissection (1.3%); 
calcified aorta (3.8%); 
bicuspid AV (44.3%); 
aortic stenosis (40.5%); 
aortic insufficiency 
(51.9%); endocarditis 
(1.3%)  
Aortic aneurysm 
(67.1%); calcified aorta 
(1.3%); bicuspid AV 
(38.0%); aortic stenosis 
(29.1%); aortic 
insufficiency (59.5%); 
endocarditis (3.8%) 
Aortic root replacement 
(52.3%); homograft (44.5%); 
stentless bioprosthetic valve 
(1.56%); Bentall procedure 
(4.69%); aortic reimplantation 
(0.78%);aortic remodelling 
(0.78%); ascending aorta 
replacement (41.4%); 
ascending aorta replacement 
with no AV procedure (14.8%); 
ascending aorta replacement 
concomitant AV replacement 
(22.7%);  ascending aorta 
replacement with concomitant 
AV repair (3.9%); ascending 
aorta with hemi arch 
replacement (5.5%); ascending 
aorta with hemi-arch 
replacement with no valve 
procedure (3.1%); ascending 
aorta with hemi arch 
replacement with AV 
replacement (1.56%); 
ascending aorta with hemi arch 
replacement with AV repair 
(0.78%); others (0.78%); patch 
Ascending aorta, proximal arch and 
root operations with or without AV 
procedures. No breakdown provided  
 
See ‘primary 
procedures’.  
See ‘primary 
procedures’. 
AI = aortic insufficiency; AV= aortic valve; ASD= atrial septal defect; CABG= coronary artery bypass graft; MIS= minimally invasive surgery; 
MS= median sternotomy; NI= no information; PFO= patent foramen ovale 
 
 
 
 
 
 
 
 
exclusion of sinus of Valsalva 
(0.78%) 
 
Wachter 
[33] 
Isolated AI (13.9%); 
isolated aortic 
aneurysm (38.9%); 
combined AI and 
aneurysm (47.2%) 
Isolated AI (9.3%); 
isolated aortic aneurysm 
(61.1%); combined AI 
and aneurysm (27.7%); 
tumour of the aortic 
glomus (1.9%) 
Elective David with or without 
additional cusp repair  
Elective David with or without 
additional cusp repair  
Atrial ablation 
(3.4%); aortic arch 
replacement 
(1.7%); septal 
myectomy and 
atrial ablation 
(0.9%) 
 
CABG (11.5%); 
atrial ablation 
(7.9%); aortic arch 
replacement 
(6.8%); surgery on 
other valves 
(5.8%).  
 
Supplementary Table 3. 
Authors description of cannulation technique and myocardial protection in the included studies 
Author et al. [ref no.] Description of cannulation Description of myocardial protection 
MIS MS MIS MS 
Abjigitova 2018 [19] • Cannulation of the 
anterior surface of 
the aortic arch 
opposite the 
innominate artery 
• Cannulation of the 
right common 
femoral vein 
• Not described • Antegrade 
cardioplegia 
• Left ventricular vent 
through pulmonary 
trunk 
• Not described 
Aharon 2017 [20] NI NI 
Burdett 2014 [21] NI NI 
Hastaoglu 2018 [22] • Aortic cannulation • Aortic cannulation 
• Innominate artery 
cannulated using 
prosthetic graft in 
patients undergoing 
ascending aortic 
replacement.   
• Antegrade 
cardioplegia 
• 32°C. 
• Left ventricular vent 
through right 
superior vein. 
• Antegrade & 
retrograde cold 
blood cardioplegia 
• Ascending aorta 
replacements 
performed using 
UCP at 24°C. 
 
Hillebrand 2018 [23] • Cannulation of the 
transition between 
the ascending aorta 
and the aortic arch 
in 32 patients. 
• Cannulation of right 
axillary artery in 2 
patients. 
• Venous cannulation 
through apex of the 
right atrium in 29 
patients. 
• Bicaval venous 
cannulation in 4 
patients requiring 
combined 
procedures.   
• Not described • Selective 
antegrade or 
retrograde 
cardioplegia 
• Not described 
Lamelas 2018 [24] • Cannulation of 
femoral or axillary 
artery 
• Venous cannulation 
of femoral vein 
• Not described • Antegrade 
cardioplegia 
• Antegrade 
cardioplegia 
• Cooling to 20°C if 
aneurysm extended 
to arch. 
Levack 2017 [25] • Cannulation of the 
distal aortic arch in 
most patients. 
• Not described • Antegrade 
cardioplegia alone. 
• Left ventricular 
venting not used.  
• Not described 
• Cannulation of the 
right subclavian 
artery in a subset of 
patients at 
surgeon’s discretion.  
Mikus 2017 [26] • Arterial cannulation: 
proximal aortic arch. 
• Venous cannulation: 
right atrium (using 
three-stage 
cannula).  
• Not described • Antegrade 
hypothermic (4°C) 
cardioplegia in to 
aortic root or 
directly in to the 
coronary ostia if 
aortic regurgitation 
was present. 
• Left ventricular vent 
through right 
superior vein. 
• Not described 
Monsefi 2018 [28] • Cannulation of right 
subclavian artery. 
• Venous cannulation 
of right atrium with 
dual stage venous 
cannula.  
• Not described • Intermittent 
retrograde and 
intermittent 
antegrade cold 
blood cardioplegia 
• Cooling to 28 to 
30°C. 
 
• Not described.  
Shreshta 2018 [30] NI NI 
 
 
Sun 2000 [31] • Cannulation of the 
left femoral artery 
• Venous cannulation 
of left femoral vein 
in 6 patients and 
right atrial 
appendage in 2 
patients. 
• Not described • Left ventricular vent 
through pulmonary 
trunk. 
• Not described 
Tabata 2007 [32] • Cannulation of the 
ascending aorta, 
aortic arch, femoral 
or right axillary 
artery. 
• Percutaneous 
femoral venous or 
direct right atrial 
cannulation 
• Not described • Antegrade and 
retrograde 
cardioplegia 
• Left ventricular vent 
is placed through 
right superior 
pulmonary vein or 
aortic valve after 
aortotomy. 
• Not described 
Wachter 2017 [33] • Cannulation of 
ascending aorta 
• Cannulation of right 
atrial appendage 
• Not described • Antegrade 
cardioplegia 
• Not described 
MIS= minimally invasive surgery; MS= median sternotomy; NI= no information
Supplementary Table 4. 
Summary of the Risk of Bias in Non-Randomised Studies- of Interventions (ROBINS-I) 
assessment for studies comparing minimally invasive aortic surgery and median sternotomy.  
 
 NI= no information. 
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Abjigitova 
[19] 
Serious Low Low Low 
 
Low Low 
 
Moderate Serious 
Aharon 
[20] 
Serious Low NI NI NI NI NI Serious 
Burdett 
[21] 
NI Serious Low NI NI NI NI Serious 
Hastaoglu 
[22] 
Serious Low Low Moderate Low Low Low Serious 
Hillebrand 
[23] 
Serious Low Low Low Low Moderate Moderate Serious 
Lamelas 
[24]  
Serious Serious Low Low Low Low Moderate Serious 
Levack 
[25]   
Serious Serious Low Low Moderate Moderate Low Serious 
Mikus 
[26] 
Serious Moderate Low Low Low Moderate Moderate Serious 
Monsefi 
[27] 
Critical Low Low Low Low Moderate Moderate Critical 
Monsefi 
[28] 
Serious Low Low Low Low Moderate Moderate Serious 
Shreshta 
[29] 
Critical Low Low Moderate Serious Low Moderate Critical 
Shreshta 
[30] 
NI NI Low NI NI NI Moderate NI 
Sun [31] Serious Low Low Low NI Low Low Serious 
Tabata 
[32] 
Moderate Low Serious Low Serious Low Low Serious 
Wachter 
[33] 
Moderate Serious Low Low Low Low Moderate Serious 
 
Supplementary Table 5. 
Timing outcomes for patients receiving minimally invasive surgery of the aorta versus median sternotomy.  
 
First Author & Year 
[ref no.] 
CPB Time (mins) 
 
AoX Time (mins) Length of ICU Stay (Days) Length of Hospital Stay (Days) 
MIS 
 
MS MIS MS MIS MS MIS MS 
Abjigitova 2018 [19] 169 IQR 156.0-
188.5 
 
186 IQR 161.0-
205.0 
148 IQR 131.3-
160.3 
153 IQR 133.0-
171.0 
 
3.0 IQR 2.0-
4.8 
3.0 IQR 2.0-
5.0 
6.5 IQR 5.0-11.0 8.0 IQR 6.0-11.0 
Aharon 2017 [20] 
 
 
178.0 SD 30.3 216.0 SD 54.4 150.9 SD 24.5 
 
180.3 SD 44.5 - 9.6 10.9 
Burdett 2014 [21] 
 
 
114 108 88 75 - 5.7 8.4 
Hastaoglu 2018 [22] 
 
97.1 SD 23.3 85.6 SD 28.4 75.7 SD 22.8 67.4 SD 26.2 1 day:100% 1 day: 80%, 2 
days: 20% 
 
4.9 SD 0.9 7.6 SD 5.5 
Hillebrand 2018 [23] 
 
 
166.1 SD 40.6 162.9 SD 45.9 122.2 SD 27.4 113.4 SD 22.6 2.5 SD 3.4 3.9 SD 7.5 13.4 SD 9.3 13.5 SD 10.2 
Lamelas 2018 [24] 
 
 
141.0 IQR 
113.0-163.0 
177.0 IQR 
150.0-201.0 
141.0 IQR 
113.0-163.0 
132.0 IQR 96.0, 
155.0 
1.21 IQR 0.9-
2.9 
2.00 IQR 1.7-
3.8 
6.0 IQR 4.0-7.0 7.0 IQR 6.0-11.0 
 
Levack 2017 [25] 
 
 
73 SD 28 83 SD 33 57 SD 23 66 SD 27 1.0 IQR 0.8-
2.0 
1.1 IQR 0.9-
2.3 
5.2 IQR 4.1-7.2 6.0 IQR 4.8-8.2 
Mikus 2017 [26] 
 
 
81.5 SD 28.4 112.8 SD 43.3 81.5 SD 28.4 94 SD 35.4 3.4 SD 3.9 4.6 SD 6.6 10.5 SD 6.4 10.7 SD 7.7 
Monsefi 2017 [28] 
 
 
184 SD 49 202 SD 40 136 SD 32 151 SD 28 1.1 SD 0.5 1.3 SD 0.8 - 
Shreshta 2018 [30] 
 
 
- - - - 
Sun 2000 [31] 
 
 
78.1 SD 6.9 88.6 SD 24.7 58.2 SD 5.2 63.3 SD 12.2 3.0 SD 0.5 2.9 SD 0.7 12.1 SD 5.4 16.1 SD 6.5 
 AoX= aortic cross-clamp; CPB= cardiopulmonary bypass; ICU= intensive care unit; IQR= interquartile range; MIS= minimally invasive surgery; 
MS= median sternotomy; SD= standard deviation. 
Values quoted as either a mean with SD or median with IQR. Hastaoglu et al. report ICU length of stay in terms of a percentage leaving ICU per 
day. 
 
 
 
 
 
 
 
 
 
 
Tabata 2007 [32] 
 
 
156 SD 52 158 SD 61 112 SD 43 116 SD 54 - 5 6 
Wachter 2017 [33] 
 
 
165.5 SD 35.6 173.2 SD 44.1 133.7 SD 23.6 132.8 SD 23.8 2.6 SD 4.9 3.4 SD 6.5 12.4 SD 7.7 13.5 SD 7.7 
 
Supplementary Table 6. 
Perioperative outcomes for the current systematic review and meta-analysis of patients receiving minimally invasive surgery of the aorta vs 
median sternotomy. 
First Author & Year 
(ref no.) 
In Hospital/30-day 
Mortality n(%) 
 
Reoperation for 
Bleeding n(%) 
Patients Requiring 
Transfusion n(%) 
pRBC use (U) 
 
Neurological 
Events n(%) 
Renal 
Impairment n(%) 
MIS MS MIS MS MIS MS MIS MS MIS MS MIS MS 
Abjigitova 2018 [19] 0(0) 1(1.1) 0(0) 6(6.6) 11(42.3) 37(40.7) 1.0 IQR 1.0-4.0 2.0 IQR 2.0-
4.0 
0(0) 0(0) 0(0) 1(1.1) 
Aharon 2017 [20] 0(0) 6(3) 21(10.6) 
 
0(0) - - - 0(0) 5(2.5) 
Burdett 2014 [21] 0(0) 0(0) 
 
- 1(14.0) 5(56.0) - 0(0) 0(0) 0 
Hastaoglu 2018 [22] 
 
0(0) 0(0) 2(4.4) 5(11.1) - 1.31 SD 0.76 1.82 SD 0.49 - - 
Hillebrand 2018 [23] 
 
1(3.0) 1(3.6) 2(6.1) 3(12.0) - 1.42 SD 2.46 1.30 SD 3.25 - - 
Lamelas 2018 [24] 2(3.2) 2(3.2) 0(0) 3(4.8) - 1.0 IQR 0.0-3.0 3.0 IQR 2.0- 
5.0 
0(0) 
 
0(0) 
 
1(1.6) 4(6.3) 
Levack 2017 [25] 
 
0(0) 2(0.4) 
 
17(3.5) 15(3.1) 60(15.0) 78(19.0) - 3(0.6) 3(0.6) 3(0.6) 6(1.2) 
Mikus 2017 [26] 
 
0(0) 5(4.5) 
 
3(6.0) 11(10.0) 26(49.0) 68(60.0) 4.9 SD 6.0 6.7 SD 11.3 - 1(2.0) 4(4.0) 
Monsefi 2018 [28] 
 
0(0) 1(1.0) 
 
8(9.0) 13(13.0) - 1.0 SD 0.5 3.4 SD 4.0 1(2) 1(1.6) - 
Shreshta 2018 [30] 
 
1(0.48) 1(0.52) 10(4.8) 14(7.3) 
 
- - 8(3.8) 8(4.1) 1(0.48) 2(1.0) 
Sun 2000 [31] 0(0) 0(0) 1(12.5) 2(9.52) - 0.89 SD 1.14 1.53 SD 1.16 - - 
 IQR= interquartile range; MIS= minimally invasive surgery; MS= median sternotomy; n= number; pRBC= packed red blood cells; SD= standard 
deviation U= units of packed red blood cells. 
a= neurological impairment reported as postoperative delirium. All other neurological events were stroke.  
Values quoted as n with percentage (%). Transfused pRBC units are quoted as either mean with SD or median with IQR. 
 
 
 
 
 
Tabata 2007 [32] 
 
0(0) 0(0) 1(1.3) 4(5.1) 27(34.1) 28(35.4) 1.0 SD 1.6 3.4 SD 3.5 1(1.3) 1(1.3) 0(0) 0(0) 
Wachter 2017a [33] 0(0) 1(1.9) 2(5.6) 6(11.1) 15(41.7) 32(59.3) 1.6 SD 2.7 4.6 SD 15.0 1(2.8) 8(14.8) 7(19.4) 20(37.7) 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1. 
Funnel plot for the perioperative mortality. Individual blue circles indicate studies included in the present study. The 
position of these circles along the horizontal axis represents the effect-estimate/risk ratio (RR). This is plotted against the 
standard error (SE) of the log-RR which is an estimate of study precision. Asymmetry is suggestive of small study or 
publication bias causing overestimation of the effect size in a meta-analysis.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2a & 2b. 
2a. Forest plot for the renal impairment this meta-analysis to compare minimally invasive surgery (MIS) of the aorta with 
median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 2b.  Funnel plots for the renal 
impairment outcome. Individual blue circles indicate studies included in the present study. The position of these circles 
along the horizontal axis represents the effect-estimate/risk ratio (RR). This is plotted against the standard error (SE) of 
the log-RR which is an estimate of study precision. Asymmetry is suggestive of small study or publication bias causing 
overestimation of the effect size in a meta-analysis.  
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3a 
3b 
Supplementary Figure 3a & 3b. 
3a. Forest plot for the stroke outcome for this meta-analysis to compare minimally invasive surgery (MIS) of the aorta with 
median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 3b.  Funnel plots for the stroke 
outcome. Individual blue circles indicate studies included in the present study. The position of these circles along the 
horizontal axis represents the effect-estimate/risk ratio (RR). This is plotted against the standard error (SE) of the log-SMD 
which is an estimate of study precision. Asymmetry is suggestive of small study or publication bias causing overestimation 
of the effect size in a meta-analysis.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Supplementary Figure 4a & 4b. 
4a. Forest plot for the aortic cross clamp (AoX) time outcome for this meta-analysis to compare minimally invasive surgery 
(MIS) of the aorta with median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 4b.  Funnel 
plots for the AoX time outcome. Individual blue circles indicate studies included in the present study. The position of these 
circles along the horizontal axis represents the effect-estimate/standardised mean difference (SMD). This is plotted 
against the standard error (SE) of the log-SMD which is an estimate of study precision. Asymmetry is suggestive of small 
study or publication bias causing overestimation of the effect size in a meta-analysis.  
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Supplementary Figure 5a & 5b. 
5a. Forest plot for the CPB time outcome for this meta-analysis to compare minimally invasive surgery (MIS) of the aorta 
with median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 5b.  Funnel plots for the CPB 
time outcome. Individual blue circles indicate studies included in the present study. The position of these circles along the 
horizontal axis represents the effect-estimate/standardised mean difference (SMD). This is plotted against the standard 
error (SE) of the log-SMD which is an estimate of study precision. Asymmetry is suggestive of small study or publication 
bias causing overestimation of the effect size in a meta-analysis.  
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Supplementary Figure 6a & 6b. 
6a. Forest plot for the length of ICU stay for this meta-analysis to compare minimally invasive surgery (MIS) of the aorta 
with median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 6b.  Funnel plots for the length 
of ICU stay outcome. Individual blue circles indicate studies included in the present study. The position of these circles 
along the horizontal axis represents the effect-estimate/standardised mean difference (SMD). This is plotted against the 
standard error (SE) of the log-SMD which is an estimate of study precision. Asymmetry is suggestive of small study or 
publication bias causing overestimation of the effect size in a meta-analysis.  
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Supplementary Figure 7a & 7b. 
7a. Forest plot for the length of hospital stay for this meta-analysis to compare minimally invasive surgery (MIS) of the 
aorta with median sternotomy (MS). (M-H = Mantel-Haenszel test; D+L= DerSimonian-Laird test.) 7b.  Funnel plots for the 
length of hospital stay outcome. Individual blue circles indicate studies included in the present study. The position of these 
circles along the horizontal axis represents the effect-estimate/standardised mean difference (SMD). This is plotted 
against the standard error (SE) of the log-SMD which is an estimate of study precision. Asymmetry is suggestive of small 
study or publication bias causing overestimation of the effect size in a meta-analysis.  
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